$34.72
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
COLL: Raising target price to $34.00
Collegium Pharmaceutical to Relocate HQ to One Lincoln in Boston
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
Overview
52-week range
$29
$51
26% of range
Avg surprise (last 3)
+6.7%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
54%
EM ±12.5% · $35 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.50 | $1.23 | +21.9% | +21.9% | +7.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.84 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $1.47 | $1.43 | +2.8% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $1.23 | $1.29 | -4.7% | — | +0.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.27 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.52 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.71 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.53 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.34 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $1.48 | $1.47 | +0.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $194M | — | $209M | $188M | $178M | — | $159M | $145M |
| Cost of revenue | $76M | — | $80M | $80M | $80M | — | $63M | $54M |
| Gross profit | $117M | — | $129M | $108M | $97M | — | $97M | $91M |
| Operating income | $31M | — | $62M | $35M | $22M | — | $35M | $47M |
| Net income | $14M | — | $32M | $12M | $2M | — | $9M | $20M |
| EPS (diluted) | $0.40 | — | $0.84 | $0.34 | $0.07 | — | $0.27 | $0.52 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $269M | $231M | $150M | $117M | $96M | $71M | $39M | $173M |
| Inventory | $43M | $41M | $38M | $38M | $37M | $36M | $38M | $28M |
| Total current assets | $746M | $691M | $614M | $549M | $528M | $482M | $444M | $510M |
| Total assets | $1.65B | $1.66B | $1.61B | $1.59B | $1.63B | $1.66B | $1.64B | $1.05B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.34B | $1.36B | $1.33B | $1.36B | $1.40B | $1.43B | $1.40B | $837M |
| Total equity | $312M | $302M | $275M | $232M | $234M | $229M | $234M | $217M |